Jump to content

Chromosome abnormality

From Wikipedia, the free encyclopedia
(Redirected from Chromosomal aberration)
Not to be confused with Chromatic aberration.

A chromosomal abnormality, chromosomal anomaly, chromosomal aberration, chromosomal mutation, or chromosomal disorder is a missing, extra, or irregular portion of chromosomal DNA.[1][2] These can occur in the form of numerical abnormalities, where there is an atypical number of chromosomes, or as structural abnormalities, where one or more individual chromosomes are altered. Chromosome mutation was formerly used in a strict sense to mean a change in a chromosomal segment, involving more than one gene.[3] Chromosome anomalies usually occur when there is an error in cell division following meiosis or mitosis. Chromosome abnormalities may be detected or confirmed by comparing an individual's karyotype, or full set of chromosomes, to a typical karyotype for the species via genetic testing.

Sometimes chromosomal abnormalities arise in the early stages of an embryo, sperm, or infant.[4] They can be caused by various environmental factors. The implications of chromosomal abnormalities depend on the specific problem, they may have quite different ramifications. Some examples are Down syndrome and Turner syndrome.

Numerical abnormality

[edit]
A karyotype of an individual with trisomy 21, showing three copies of chromosome 21.
Error within meiosis segregation resulting in tetraploid daughter cells with 4 sets of chromosomes instead of two

Maintaining a euploid state, where cells contain the correct number of chromosome sets, is essential for genomic stability. [5] Aneuploidy, characterized by an abnormal number of chromosomes, occurs when an individual is missing a chromosome from a pair (monosomy) or has an additional chromosome (trisomy). [6][7][8] This may be either full, involving a whole chromosome, or partial, where only part of a chromosome is missing or added.[6][7][8] Aneuploidy may arise from meiosis segregation errors such as nondisjunction, premature disjunction, or anaphase lag during meiosis I or II. [9] For aneuploidy, nondisjunction, the most frequent error, particularly in oocyte formation, occurs when replicated chromosomes fail to separate properly, leading to germ cells with an extra or missing chromosome.[9] Additionally, polyploidy occurs when cells contain more than two sets of chromosomes. [10] Polyploidy encompasses various forms, including triploid (three sets of chromosomes) and tetraploid (four sets of chromosomes). [5] Tetraploidy often arises from developmental errors during mitosis, such as cytokinesis failure, endoreplication, mitotic slippage, and cell fusion. These errors can subsequently lead to aneuploidy. [5]

A karyotype of an individual with Turner Syndrome, where there is only a single X chromosome.

Aneuploidy can occur with sex chromosomes or autosomes.[11] Rather than having monosomy, or only one copy, the majority of aneuploid people have trisomy, or three copies of one chromosome.[1] An example of trisomy in humans is Down syndrome, which is a developmental disorder caused by an extra copy of chromosome 21; the disorder is therefore also called "trisomy 21".[12] An example of monosomy in humans is Turner syndrome, where the individual is born with only one sex chromosome, an X.[13]

Sperm aneuploidy

[edit]

Exposure of males to certain lifestyle, environmental and/or occupational hazards may increase the risk of aneuploid spermatozoa.[14] In particular, risk of aneuploidy is increased by tobacco smoking,[15][16] and occupational exposure to benzene,[17] insecticides,[18][19] and perfluorinated compounds.[20] Increased aneuploidy is often associated with increased DNA damage in spermatozoa.


Structural abnormalities

[edit]
The three major single-chromosome mutations: deletion (1), duplication (2) and inversion (3).
The two major two-chromosome mutations: insertion (1) and translocation (2).

Structural abnormalities in chromosomes may result from breakage and improper realignment of chromosome segments. [1] When the structure of a chromosome is altered, it can result in unbalanced rearrangements, balanced rearrangements, ring chromosomes, and isochromosomes. [1][21] To expand, these abnormilities may be defined as follows: [1][21]

  • Unbalanced rearrangements includes missing or additional genetic information in chromosomes. [1] They include:
  • Balanced rearrangements includes the alteration of chromsome segments but the genetic information is not lost or gained.[1] They include:
    • Inversions: A portion of the chromosome has broken off, turned upside down, and reattached, therefore the genetic material is inverted.[1]
    • Translocations: A portion of one chromosome has been transferred to another chromosome.[1] There are two main types of translocations:
Robertsonian translocation. Two chromosomes with the removal of their p (short) arms, and fusion at the centromere with their q (long) arms.
  • Rings: A portion of a chromosome (the ends) has broken off and formed a circle or ring. This happens with or without the loss of genetic material.[1]
Formation of a ring chromosome
  • Isochromosome: Formed by the mirror image copy of a chromosome segment including the centromere.[21] Specifically, they form when one arm of a chromosome is lost, and the remaining arm duplicates.[1]
Isochromosome formation

Chromosome instability syndromes are a group of disorders characterized by chromosomal instability and breakage. They often lead to an increased tendency to develop certain types of malignancies. [22]

Inheritance

[edit]
Autosomal dominant and autosomal recessive inheritance patterns

Constitutional chromosome abnormalities (present at beginning of development) arise during gametogenesis or embryogenesis, affecting a significant proportion of an organism’s cells. [23] These inherited abnormalities most commonly occur as errors in the egg or sperm, meaning the anomaly is present in every cell of the body. [1] Factors such as maternal age and environmental influences contribute to the occurrence of these genetic errors. [1] Offspring inherit two copies of each gene, one from each parent, and mutations (often caused by disease) may be passed down through generations. [24] The diseases that follow a single-gene inheritance pattern are relatively rare but affect millions of individuals. [24] This can be represented through the Mendelian inheritance patterns: [24][25]

X-linked dominant inheritance patterns, differing between maternal and paternal origin, on offspring
X-linked recessive inheritance patterns, differing between maternal and paternal origin, on offspring
  • Autosomal recessive: Both parents are carriers of the mutation (though it may not appear in every generation). The disorder manifests only when both copies of the inherited gene are mutated.[24] Examples include tay-Sachs disease, sickle cell anemia, and cystic fibrosis.[24]
  • X-linked inheritance: Mutated X chromosomes may be inherited in a dominant or recessive manner. Within X-linked recessive inheritance, males are more frequently affected than females. Since males have only one X chromosome, they will express the disease if that single X carries the mutation. Examples include hemophilia and fabry disease.[25] In contrast, females, with two X chromosomes, must inherit the mutated gene from both parents for the disorder to manifest. X-linked dominant diseases can affect both males and females. A father with an X-linked dominant trait may only pass it to his daughters, while a mother can pass the trait to both sons and daughters. An example of this is incontinentia pigmenti.[25]
Mitochondrial inheritance pattern and its implication on offspring from a maternal and paternal origin.


Given these patterns of inheritance, chromosome studies are often conducted on parents when a child is found to have a chromosomal anomaly. If the parents do not exhibit the abnormality, it was not inherited but may be passed down in subsequent generations. [26]

Chromosomal abnormalities can also arise from de novo mutations within an individual. [27] De novo mutations are spontaneous, somatic mutations that occur without prior inheritance, and they can emerge at various stages of life, including during the parental germline, embryonic or fetal development, or later in life due to aging. [28] These mutations may occur during gametogenesis or postzygotically, resulting in new mutations that appear in a single generation without prior evidence of mutation in the parental chromosomes. [29] Approximately 7% of de novo mutations are present as high-level mosaic mutations. [29] Genetic mosaicism, which refers to a post-zygotic mutation, occurs when an individual possesses two or more genetically distinct cell populations derived from a single fertilized egg. [9][29] This can lead to chromosomal abnormalities, and these mutations may be present in somatic cells, germ cells, or both, in the case of gonosomal mosaicism, where mutations exist in both somatic and germline cells. [28] Somatic mosaicism involves multiple cell lineages in somatic cells, while germline mosaicism occurs in multiple lineages within germline cells, allowing the mutation to be passed to offspring. [9] An example of a chromosomal abnormality resulting from genetic mosaicism is Turner syndrome. [9]

Acquired chromosome abnormalities

[edit]

Acquired chromosomal abnormalities represent genetic alterations that manifest during an individual's lifetime, as opposed to being inherited from their parents.[23] These modifications predominantly occur within somatic cells and are characterized by their non-heritable nature. [23] Typically, they arise from mutations that transpire during the process of DNA replication or as a consequence of exposure to various environmental factors [30]. In contrast to constitutional chromosomal abnormalities, which are present at birth, acquired abnormalities occur during adulthood and are confined to specific clones of cells, thereby inhibiting their distribution throughout the body. [30]

The development of chromosomal abnormalities and malignancies can be attributed to environmental exposures or may occur spontaneously during DNA replication. [30][31] Spontaneous replication errors typically occur due to DNA polymerase synthesizing new polynucleotides while evading proofreading functions, leading to mismatches in base pairing. [31] Throughout a human's lifetime, individuals may encounter mutagens (which are agents that induce mutations) that lead to chromosomal mutations. These mutations arise when a mutagen interacts with parental DNA, typically affecting one strand, resulting in structural alterations that hinder the successful base pairing with the modified nucleotide [31]. Consequently, daughter molecules inherit these mutations, which may further accumulate additional damage, subsequently being passed down to the next generations of cells. [32] Mutagens can be classified as physical, chemical, or biological:

  • Chemical: Common chemical mutagens include base analogs (molecules that resemble nitrogenous bases), deaminating agents (which remove amino groups), alkylating agents, and intercalating agents. [31]
  • Physical: The most prevalent sources of physical mutagens are exposure to UV radiation, which induces dimerization of adjacent pyrimidine bases, and ionizing radiation, which typically causes point mutations, insertions, or deletions. [31] Heat can also function as a mutagen by promoting the cleavage of the β-N-glycosidic bond, which connects the base to the sugar part of the nucleotide, through water-induced processes. [31]
  • Biological: Biological mutagens are introduced through exposure to viruses, bacteria, and/or transposons and insertion sequences (IS). [33] Transposons and IS can move through DNA by 'jumping,' disrupting the functionality of chromosomal DNA. The insertion of viral DNA can lead to genetic disruption, while bacteria may produce reactive oxygen species (ROS) that cause inflammation and DNA damage, resulting in decreased repair efficiency. [33]

Sporadic cancers are those that develop due to mutations that are not inherited; in these cases, normal cells gradually accumulate mutations and cellular damage. [34] Most cancers, if not all, could cause chromosome abnormalities,[35] with either the formation of hybrid genes and fusion proteins, deregulation of genes and overexpression of proteins, or loss of tumor suppressor genes (see the "Mitelman Database" [36] and the Atlas of Genetics and Cytogenetics in Oncology and Haematology,[37]). Approximately 90% of cancers exhibit chromosomal instability (CIN), characterized by the frequent gain or loss of entire chromosome segments. [38] This phenomenon contributes to tumor aneuploidy and intra-tumor heterogeneity, which are commonly observed in most human cancers. [30][38] For instance, certain consistent chromosomal abnormalities can turn normal cells into a leukemic cell such as the translocation of a gene, resulting in its inappropriate expression.[39]

DNA damage during spermatogenesis

[edit]

DNA damage during spermatogenesis plays a crucial role in chromosomal abnormalities and male fertility. In the early stages of sperm development, DNA repair mechanisms such as homologous recombination (HR) and mismatch repair (MMR) efficiently correct replication errors and double-strand breaks (DSBs)[40] [41]. However, as spermatogenesis progresses, DNA repair capacity declines due to changes in how DNA is packaged inside sperm cells.

Spermatogenesis occurs in three phases: mitosis (spermatocytogenesis), meiosis, and spermiogenesis. During spermiogenesis, the DNA becomes more tightly packed to fit inside the sperm head[42]. This happens because histone proteins, which normally help organize DNA, are replaced with transition proteins (TNP1, TNP2) and then protamines (PRM1, PRM2). While this packaging protects the DNA, it also makes it harder for repair enzymes to fix any damage[43]. As a result, non-homologous end joining (NHEJ), an error-prone repair process, becomes the main repair mechanism, increasing the risk of mutations.

Oxidative stress is another major factor contributing to DNA damage in sperm cells. Reactive oxygen species (ROS), produced both inside sperm and from external sources such as immune cells in seminal fluid, can break DNA strands. High ROS levels can overwhelm antioxidant defences, leading to further damage and triggering cell death pathways[44].

Normally, defective sperm cells are removed through apoptosis, a controlled cell death process. However, if this system fails—such as when there is an imbalance between pro-apoptotic (BAX) and anti-apoptotic (BCL-2) factors—damaged sperm may survive[45]. If these sperm fertilize an egg, the oocyte's repair mechanisms may attempt to fix the damage[46].

The maternal repair machinery is capable of correcting sperm DNA damage post-fertilization, but errors in this process can result in chromosomal structural aberrations in the developing zygote[47]. Notably, exposure to DNA-damaging agents, such as the chemotherapy drug Melphalan, can induce inter-strand DNA crosslinks that escape paternal repair, potentially leading to chromosomal abnormalities due to maternal misrepair. Therefore, both pre- and post-fertilization DNA repair are crucial for maintaining genome integrity and preventing genetic defects in the offspring[48].

DNA damage in sperm has been linked to infertility, increased miscarriage risk, and conditions such as aneuploidy and structural chromosomal rearrangements. Understanding how DNA damage occurs and is repaired during spermatogenesis is important for studying male reproductive health and genetic inheritance[49].

Detection

[edit]

Chromosomal abnormalities can be detected at either postnatal testing or prenatal screening, which includes prenatal diagnosis.[50] Early detection is crucial for enabling parents to assess their upcoming pregnancy options.[51]

Common techniques used to detect diseases resulting from chromosomal abnormalities:

Karyotyping has been the traditional method used to detect chromosomal abnormalities. It requires entire set of chromosomes to be able to identify fetal aneuploidy and variations in structural arrangements, which could be a result of insertions, inversions, duplications or deletions of chromosomes.[9] The samples used to obtain results from fetal karyotyping can be acquired through various sampling techniques. Amongst the aneuploidy testings, those which use amniotic fluid is preferred due its benefit of having high sensitivity with relatively low risks.[51]

For increased resolution of screening, Chromosomal Microassy Analysis (CMA) can be used which is based on comparative genomic hybridization to identify copy number variations. This alternative method to karyotyping reduces result uncertainty through its use of invasive fetal cell collection technique.[51]

FISH technique detects chromosomal abnormalities through labeling of the chromosome by fluorescence using specialized probes. It is important that these probes are validated before use as they are carefully regulated by the Food and Drug Administration (FDA).[51]

FISH is a technique used for the treatment of specific cases such as Multiple myeloma (MM) and can be used to analyze bone marrow samples to identify changes in chromosomes at a single-cell level.[52] For the treatment of MM relapse, acquired chromosomal abnormalities such as del (17p), amp (1q) and Tetraploidy can be analyzed to guide future therapy development and updated prognosis.[52]

Spectral Karyotyping is a recent technology developed from the FISH technique that colors each human chromosome in a different color for identification in analysis.[53] Through the use of fluorescent dyes such as Cy5, Texas red and spectrum green, 24 distinguishable colors can be generated using imaging spectroscopy.[53]

Depending on the information one wants to obtain, different techniques and samples are needed.[citation needed]

Nomenclature

[edit]
  • Three chromosomal abnormalities with ISCN nomenclature, with increasing complexity: (A) A tumour karyotype in a male with loss of the Y chromosome, (B) Prader–Willi Syndrome i.e. deletion in the 15q11-q12 region and (C) an arbitrary karyotype that involves a variety of autosomal and allosomal abnormalities.[54]
    Three chromosomal abnormalities with ISCN nomenclature, with increasing complexity: (A) A tumour karyotype in a male with loss of the Y chromosome, (B) Prader–Willi Syndrome i.e. deletion in the 15q11-q12 region and (C) an arbitrary karyotype that involves a variety of autosomal and allosomal abnormalities.[54]
  • Human karyotype with annotated bands and sub-bands as used for the nomenclature of chromosome abnormalities. It shows dark and white regions as seen on G banding. Each row is vertically aligned at centromere level. It shows 22 homologous autosomal chromosome pairs, both the female (XX) and male (XY) versions of the two sex chromosomes, as well as the mitochondrial genome (at bottom left).
    Human karyotype with annotated bands and sub-bands as used for the nomenclature of chromosome abnormalities. It shows dark and white regions as seen on G banding. Each row is vertically aligned at centromere level. It shows 22 homologous autosomal chromosome pairs, both the female (XX) and male (XY) versions of the two sex chromosomes, as well as the mitochondrial genome (at bottom left).
Further information: Karyotype

The International System for Human Cytogenomic Nomenclature (ISCN) is an international standard for human chromosome nomenclature, which includes band names, symbols and abbreviated terms used in the description of human chromosome and chromosome abnormalities. Abbreviations include a minus sign (-) for chromosome deletions, and del for deletions of parts of a chromosome.[55]

See also

[edit]

References

[edit]
  1. ^ a b c d e f g h i j k l m n o p q "Chromosomal Abnormalities", Understanding Genetics: A New York, Mid-Atlantic Guide for Patients and Health Professionals, Genetic Alliance, 2009-07-08, retrieved 2023-09-27
  2. ^ NHGRI. 2006. Chromosome Abnormalities Archived 2006-09-25 at the Wayback Machine
  3. ^ Rieger, R., Michaelis, A., Green, M.M. (1968). "Mutation". A glossary of genetics and cytogenetics: Classical and molecular. New York: Springer-Verlag. ISBN 978-0-387-07668-3.
  4. ^ Chen H (2006). Atlas of genetic diagnosis and counseling. Totowa, N.J: Humana Press. ISBN 978-1-58829-681-8.
  5. ^ a b c Orr B, Godek KM, Compton D (2015-06-29). "Aneuploidy". Current Biology. 25 (13): R538 – R542. Bibcode:2015CBio...25.R538O. doi:10.1016/j.cub.2015.05.010. ISSN 0960-9822. PMC 4714037. PMID 26126276.
  6. ^ a b "Chromosome abnormalities and genetic counseling | WorldCat.org". search.worldcat.org. Retrieved 2025-04-03.
  7. ^ a b "Content - Health Encyclopedia - University of Rochester Medical Center". www.urmc.rochester.edu. Retrieved 2025-04-03.
  8. ^ a b Gardner, R. J. M. (2012). Chromosome abnormalities and genetic counseling. Sutherland, Grant R., Shaffer, Lisa G. (4th ed.). Oxford: Oxford University Press. ISBN 978-0-19-974915-7. OCLC 769344040.
  9. ^ a b c d e f Queremel Milani DA, Tadi P (2025), "Genetics, Chromosome Abnormalities", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 32491623, retrieved 2025-04-03
  10. ^ Potapova T, Gorbsky G (2017-02-08). "The Consequences of Chromosome Segregation Errors in Mitosis and Meiosis". Biology. 6 (1): 12. doi:10.3390/biology6010012. ISSN 2079-7737. PMC 5372005. PMID 28208750.
  11. ^ "Chromosomal Abnormalities: Aneuploidies | Learn Science at Scitable". www.nature.com. Retrieved 2025-04-04.
  12. ^ Patterson D (2009-07-01). "Molecular genetic analysis of Down syndrome". Human Genetics. 126 (1): 195–214. doi:10.1007/s00439-009-0696-8. ISSN 1432-1203. PMID 19526251. S2CID 10403507.
  13. ^ "Turner Syndrome". National Institute of Child Health and Human Development. Retrieved 2020-11-17.
  14. ^ Templado C, Uroz L, Estop A (2013). "New insights on the origin and relevance of aneuploidy in human spermatozoa". Mol. Hum. Reprod. 19 (10): 634–43. doi:10.1093/molehr/gat039. PMID 23720770.
  15. ^ Shi Q, Ko E, Barclay L, Hoang T, Rademaker A, Martin R (2001). "Cigarette smoking and aneuploidy in human sperm". Mol. Reprod. Dev. 59 (4): 417–21. doi:10.1002/mrd.1048. PMID 11468778. S2CID 35230655.
  16. ^ Rubes J, Lowe X, Moore D, Perreault S, Slott V, Evenson D, Selevan SG, Wyrobek AJ (1998). "Smoking cigarettes is associated with increased sperm disomy in teenage men". Fertil. Steril. 70 (4): 715–23. doi:10.1016/S0015-0282(98)00261-1. PMID 9797104.
  17. ^ Xing C, Marchetti F, Li G, Weldon RH, Kurtovich E, Young S, Schmid TE, Zhang L, Rappaport S, Waidyanatha S, Wyrobek AJ, Eskenazi B (2010). "Benzene exposure near the U.S. permissible limit is associated with sperm aneuploidy". Environ. Health Perspect. 118 (6): 833–9. Bibcode:2010EnvHP.118..833X. doi:10.1289/ehp.0901531. PMC 2898861. PMID 20418200.
  18. ^ Xia Y, Bian Q, Xu L, Cheng S, Song L, Liu J, Wu W, Wang S, Wang X (2004). "Genotoxic effects on human spermatozoa among pesticide factory workers exposed to fenvalerate". Toxicology. 203 (1–3): 49–60. Bibcode:2004Toxgy.203...49X. doi:10.1016/j.tox.2004.05.018. PMID 15363581. S2CID 36073841.
  19. ^ Xia Y, Cheng S, Bian Q, Xu L, Collins MD, Chang HC, Song L, Liu J, Wang S, Wang X (2005). "Genotoxic effects on spermatozoa of carbaryl-exposed workers". Toxicol. Sci. 85 (1): 615–23. doi:10.1093/toxsci/kfi066. PMID 15615886.
  20. ^ Governini L, Guerranti C, De Leo V, Boschi L, Luddi A, Gori M, Orvieto R, Piomboni P (2014). "Chromosomal aneuploidies and DNA fragmentation of human spermatozoa from patients exposed to perfluorinated compounds". Andrologia. 47 (9): 1012–9. doi:10.1111/and.12371. hdl:11365/982323. PMID 25382683. S2CID 13484513.
  21. ^ a b c d e f g "Chromosome Abnormalities". atlasgeneticsoncology.org. Archived from the original on 14 August 2006. Retrieved 9 May 2018.
  22. ^ Rayi A, Hozayen S (2025), "Chromosome Instability Syndromes", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 30725883, retrieved 2025-04-04
  23. ^ a b c McFadden DE, Friedman JM (1997-12-12). "Chromosome abnormalities in human beings". Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 396 (1): 129–140. Bibcode:1997MRFMM.396..129M. doi:10.1016/S0027-5107(97)00179-6. ISSN 0027-5107. PMID 9434864.
  24. ^ a b c d e f g h i Alliance G, Screening Services TN (2009-07-08), "INHERITANCE PATTERNS", Understanding Genetics: A New York, Mid-Atlantic Guide for Patients and Health Professionals, Genetic Alliance, retrieved 2025-03-31
  25. ^ a b c Basta M, Pandya AM (2025), "Genetics, X-Linked Inheritance", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 32491315, retrieved 2025-04-05
  26. ^ "Genetic Testing (for Parents)". kidshealth.org. Retrieved 2025-04-05.
  27. ^ Liu Y, Shen J, Yang R, Zhang Y, Jia L, Guan Y (2022-03-19). Bevilacqua A (ed.). "The Relationship between Human Embryo Parameters and De Novo Chromosomal Abnormalities in Preimplantation Genetic Testing Cycles". International Journal of Endocrinology. 2022: 1–11. doi:10.1155/2022/9707081. ISSN 1687-8345. PMC 8957472. PMID 35345425.
  28. ^ a b Mohiuddin M, Kooy RF, Pearson CE (2022-09-26). "De novo mutations, genetic mosaicism and human disease". Frontiers in Genetics. 13. doi:10.3389/fgene.2022.983668. ISSN 1664-8021. PMC 9550265. PMID 36226191.
  29. ^ a b c Acuna-Hidalgo R, Veltman JA, Hoischen A (2016-11-28). "New insights into the generation and role of de novo mutations in health and disease". Genome Biology. 17 (1): 241. doi:10.1186/s13059-016-1110-1. ISSN 1474-760X. PMC 5125044. PMID 27894357.
  30. ^ a b c d McGranahan N, Burrell RA, Endesfelder D, Novelli MR, Swanton C (June 2012). "Cancer chromosomal instability: therapeutic and diagnostic challenges". EMBO Reports. 13 (6): 528–538. doi:10.1038/embor.2012.61. ISSN 1469-221X. PMC 3367245. PMID 22595889.
  31. ^ a b c d e f Brown TA (2002), "Mutation, Repair and Recombination", Genomes. 2nd edition, Wiley-Liss, retrieved 2025-03-31
  32. ^ "Inherited Mutations and Cancer". Inherited Mutations and Cancer. Retrieved 2025-03-31.
  33. ^ a b Kapali D (2023-08-03). "Mutagens- Definition, Types (Physical, Chemical, Biological)". microbenotes.com. Retrieved 2025-03-31.
  34. ^ "Inherited Mutations and Cancer". Inherited Mutations and Cancer. Retrieved 2025-03-31.
  35. ^ "Chromosomes, Leukemias, Solid Tumors, Hereditary Cancers". atlasgeneticsoncology.org. Archived from the original on 28 January 2015. Retrieved 9 May 2018.
  36. ^ "Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer". Archived from the original on 2016-05-29.
  37. ^ "Atlas of Genetics and Cytogenetics in Oncology and Haematology". atlasgeneticsoncology.org. Archived from the original on 2011-02-23.
  38. ^ a b Kou F, Wu L, Ren X, Yang L (June 2020). "Chromosome Abnormalities: New Insights into Their Clinical Significance in Cancer". Molecular Therapy - Oncolytics. 17: 562–570. doi:10.1016/j.omto.2020.05.010. ISSN 2372-7705. PMC 7321812. PMID 32637574.
  39. ^ Chaganti RS, Nanjangud G, Schmidt H, Teruya-Feldstein J (October 2000). "Recurring chromosomal abnormalities in non-Hodgkin's lymphoma: biologic and clinical significance". Seminars in Hematology. 37 (4): 396–411. doi:10.1016/s0037-1963(00)90019-2. ISSN 0037-1963. PMID 11071361.
  40. ^ Baarends W (2001-01-01). "DNA repair mechanisms and gametogenesis". Reproduction. 121 (1): 31–39. doi:10.1530/reprod/121.1.31. ISSN 1470-1626.
  41. ^ Talibova G, Bilmez Y, Ozturk S (October 2022). "DNA double-strand break repair in male germ cells during spermatogenesis and its association with male infertility development". DNA Repair. 118: 103386. doi:10.1016/j.dnarep.2022.103386. PMID 35963140.
  42. ^ Marchetti F, Bishop J, Gingerich J, Wyrobek AJ (2015-01-08). "Meiotic interstrand DNA damage escapes paternal repair and causes chromosomal aberrations in the zygote by maternal misrepair". Scientific Reports. 5 (1): 7689. Bibcode:2015NatSR...5.7689M. doi:10.1038/srep07689. ISSN 2045-2322. PMC 4286742. PMID 25567288.
  43. ^ Cao Y, Wang S, Qin Z, Xiong Q, Liu J, Li W, Li L, Ao F, Wei Z, Wang L (2025-02-24). "Male germ cells with Bag5 deficiency show reduced spermiogenesis and exchange of basic nuclear proteins". Cellular and Molecular Life Sciences. 82 (1): 92. doi:10.1007/s00018-025-05591-2. ISSN 1420-9071. PMC 11850669. PMID 39992433.
  44. ^ Wang Y, Fu X, Li H (2025-02-05). "Mechanisms of oxidative stress-induced sperm dysfunction". Frontiers in Endocrinology. 16. doi:10.3389/fendo.2025.1520835. ISSN 1664-2392. PMC 11835670. PMID 39974821.
  45. ^ Sharma P, Kaushal N, Saleth LR, Ghavami S, Dhingra S, Kaur P (August 2023). "Oxidative stress-induced apoptosis and autophagy: Balancing the contrary forces in spermatogenesis". Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1869 (6): 166742. doi:10.1016/j.bbadis.2023.166742.
  46. ^ Li N, Wang H, zou S, Yu X, Li J (January 2025). "Perspective in the Mechanisms for Repairing Sperm DNA Damage". Reproductive Sciences. 32 (1): 41–51. doi:10.1007/s43032-024-01714-5. ISSN 1933-7191. PMID 39333437.
  47. ^ Marchetti F, Essers J, Kanaar R, Wyrobek AJ (2007-11-06). "Disruption of maternal DNA repair increases sperm-derived chromosomal aberrations". Proceedings of the National Academy of Sciences. 104 (45): 17725–17729. Bibcode:2007PNAS..10417725M. doi:10.1073/pnas.0705257104. ISSN 0027-8424. PMC 2077046. PMID 17978187.
  48. ^ Deans AJ, West SC (July 2011). "DNA interstrand crosslink repair and cancer". Nature Reviews Cancer. 11 (7): 467–480. doi:10.1038/nrc3088. ISSN 1474-175X. PMC 3560328. PMID 21701511.
  49. ^ Zini A (2006-08-29). "Sperm DNA damage: clinical significance in the era of assisted reproduction". Canadian Medical Association Journal. 175 (5): 495–500. doi:10.1503/cmaj.060218. ISSN 0820-3946. PMC 1550758. PMID 16940270.
  50. ^ Fonda Allen J, Stoll K, Bernhardt BA (2016-02-01). "Pre- and post-test genetic counseling for chromosomal and Mendelian disorders". Seminars in Perinatology. The Changing Paradigm of Perinatal screening for Birth Defects. 40 (1): 44–55. doi:10.1053/j.semperi.2015.11.007. ISSN 0146-0005. PMC 4826755. PMID 26718445.
  51. ^ a b c d Hixson L, Goel S, Schuber P, Faltas V, Lee J, Narayakkadan A, Leung H, Osborne J (2015-10-01). "An Overview on Prenatal Screening for Chromosomal Aberrations". SLAS Technology. 20 (5): 562–573. doi:10.1177/2211068214564595. ISSN 2472-6303. PMID 25587000.
  52. ^ a b Locher M, Jukic E, Vogi V, Keller MA, Kröll T, Schwendinger S, Oberhuber K, Verdorfer I, Mühlegger BE, Witsch-Baumgartner M, Nachbaur D, Willenbacher W, Gunsilius E, Wolf D, Zschocke J (2023). "Amp(1q) and tetraploidy are commonly acquired chromosomal abnormalities in relapsed multiple myeloma". European Journal of Haematology. 110 (3): 296–304. doi:10.1111/ejh.13905. ISSN 1600-0609. PMC 10107198. PMID 36433728.
  53. ^ a b Imataka G, Arisaka O (2012-01-01). "Chromosome Analysis Using Spectral Karyotyping (SKY)". Cell Biochemistry and Biophysics. 62 (1): 13–17. doi:10.1007/s12013-011-9285-2. ISSN 1559-0283. PMC 3254861. PMID 21948110.
  54. ^ Warrender JD, Moorman AV, Lord P (2019). "A fully computational and reasonable representation for karyotypes". Bioinformatics. 35 (24): 5264–5270. doi:10.1093/bioinformatics/btz440. PMC 6954653. PMID 31228194.
    - "This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/)"
  55. ^ "ISCN Symbols and Abbreviated Terms". Coriell Institute for Medical Research. Retrieved 2022-10-27.
[edit]
Retrieved from "https://en.wikipedia.org/w/index.php?title=Chromosome_abnormality&oldid=1284027523"